|
|
|
|
|
|
|
|
| IN ZEICHNUNG BIS 05.02.2026 |
| CALLABLE MULTI BARRIER REVERSE CONVERTIBLES |
| Coupon p.a. | | Basiswerte | | Barriere | | Währung | | Laufzeit | | Valor |
| 8.00% | | Givaudan, Novartis, Partners Group | | 59% | | CHF | | 2.0 Jahre | | 150558835 |
| 13.00% | | ABB, Sika, Swiss Re, UBS | | 69% | | CHF | | 1.5 Jahre | | 148457921 |
| 13.40% | | Commerzbank, Deutsche Bank, UniCredit | | 59% | | CHF | | 1.0 Jahr | | 148457922 |
| 11.00% | | Kühne + Nagel, Logitech, Temenos | | 55% | | CHF | | 1.0 Jahr | | 148457923 |
| 13.00% | | Gold, Palladium, Platinum, Silver | | 59% | | EUR | | 1.5 Jahre | | 148457924 |
| 11.60% | | Alphabet, IBM, Microsoft | | 49% | | USD | | 1.5 Jahre | | 148457925 |
|
| • | | Emittentin: Leonteq Securities AG, Guernsey |
| • | | Garantin: Aargauische Kantonalbank, Aarau (Rating der Garantin: S&P AA+) |
|
|
|
|
|
|
|
|
|
| IN ZEICHNUNG BIS 06.02.2026 |
| CALLABLE MULTI BARRIER REVERSE CONVERTIBLES |
| Coupon p.a. | | Basiswerte | | Barriere | | Währung | | Laufzeit | | Valor |
| 8.40% | | Richemont, Nestlé, Novartis, Roche | | 59% | | CHF | | 2.0 Jahre | | 149398533 |
| 5.60% | | EURO STOXX Banks Index, S&P 500, SMI | | 64% | | CHF | | 2.0 Jahre | | 149398535 |
| 7.70% | | Roche, Swisscom, UBS | | 59% | | CHF | | 1.75 Jahre | | 149398537 |
| 11.00% | | Julius Bär, Partners Group, Swissquote | | 59% | | CHF | | 1.5 Jahre | | 149398538 |
| 8.80% | | Holcim, Lonza, Partners Group | | 59% | | CHF | | 1.5 Jahre | | 149398540 |
| 8.00% | | Barry Callebaut, Richemont, Givaudan, Nestlé | | 49% | | CHF | | 1.5 Jahre | | 149398544 |
| 18.00% | | Biontech, Moderna | | 49% | | CHF | | 1.0 Jahr | | 149398548 |
| 13.00% | | Barrick Mining, Pan American Silver | | 49% | | CHF | | 1.0 Jahr | | 149398550 |
| 15.00% | | Allianz, Commerzbank, Deutsche Bank, Munich Re | | 55% | | EUR | | 1.5 Jahre | | 149398552 |
| 12.00% | | Chevron, Exxon Mobil, SLB | | 59% | | USD | | 1.5 Jahre | | 149398553 |
|
| • | | Emittentin: Basler Kantonalbank (Rating: Fitch AAA, S&P AA+) |
|
|
|
|
|
|
